Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr 7;29(4):1363-1365.
doi: 10.1016/j.ymthe.2021.03.001. Epub 2021 Mar 10.

Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter

Affiliations
Comment

Doxorubicin-induced cardiomyopathy: TERT gets to the heart of the matter

Bart De Geest et al. Mol Ther. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Redox cycling of doxorubicin in the mitochondria Doxorubicin is bioactivated by complex I of the mitochondrial respiratory chain at the expense of NADH. This is followed by the rapid re-oxidation of the semiquinone radical in the presence of molecular oxygen to generate superoxide anion-free radicals. Subsequently, further primary reactive oxygen species and secondary reactive oxygen species are produced, leading to oxidative stress.

Comment on

  • Telomerase therapy attenuates cardiotoxic effects of doxorubicin.
    Chatterjee S, Hofer T, Costa A, Lu D, Batkai S, Gupta SK, Bolesani E, Zweigerdt R, Megias D, Streckfuss-Bömeke K, Brandenberger C, Thum T, Bär C. Chatterjee S, et al. Mol Ther. 2021 Apr 7;29(4):1395-1410. doi: 10.1016/j.ymthe.2020.12.035. Epub 2021 Jan 1. Mol Ther. 2021. PMID: 33388418 Free PMC article.

References

    1. Chatterjee S., Hofer T., Costa A., Lu D., Batkai S., Gupta S.K. Telomerase therapy attenuates cardiotoxic effects of doxorubicin. Mol. Ther. 2021;29:1395–1410. this issue. - PMC - PubMed
    1. Wallace K.B., Sardão V.A., Oliveira P.J. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy. Circ. Res. 2020;126:926–941. - PMC - PubMed
    1. Cova D., De Angelis L., Monti E., Piccinini F. Subcellular distribution of two spin trapping agents in rat heart: possible explanation for their different protective effects against doxorubicin-induced cardiotoxicity. Free Radic. Res. Commun. 1992;15:353–360. - PubMed
    1. Zheng Q., Huang J., Wang G. Mitochondria, Telomeres and Telomerase Subunits. Front. Cell Dev. Biol. 2019;7:274. - PMC - PubMed
    1. Haendeler J., Dröse S., Büchner N., Jakob S., Altschmied J., Goy C., Spyridopoulos I., Zeiher A.M., Brandt U., Dimmeler S. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler. Thromb. Vasc. Biol. 2009;29:929–935. - PubMed